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Received 29 August 2005; received in revised form 16 November 2005; accepted 21 November 2005AbstractObjective:Myasthenia gravis (MG) affects women at childbearing age. Therefore, the question arises if these patients should become pregnant
and if thymectomy has a positive effect on the course of MG in pregnant patients. Methods: Fifteen pregnancies had been followed
retrospectively. All patients underwent transsternal radical thymectomy for MG. The course of MG in the period before, during, and after
the pregnancy was scored according to Ossermann’s classification. The effect of thymectomy on delivery and on the newborns was evaluated.
Results: Patients were divided in two groups: pregnancies before (group I, n = 8) and after (group II, n = 7) thymectomy. During pregnancy, in
group I, one deterioration was observed and in seven patients the disease was unchanged. In group II, one deterioration, five unchanged courses,
and one improvement were observed. In the postpartum period, in group I, seven patients did not change and one improved. In group II, two
deteriorations, three unchanged courses, and two improvements were observed. Before pregnancy, group II patients were in a better Ossermann
stage in comparison with those in group I. Eight of the 12 deliveries were spontaneous (three abortus). Myasthenic symptomswere observed in two
newborns in group I. Conclusion: Our data suggest that MG is not prohibitive to have children. The course of MG after transsternal radical
thymectomy is often ameliorated. A better MG-stage, reached after thymectomy, before pregnancy seems to be correlated with a better course
during pregnancy.
# 2005 Elsevier B.V. All rights reserved.
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Myasthenia gravis (MG) is an acquired chronic autoimmune
disease affecting the motor endplates of the voluntary
muscles. It is characterized by excessive fatigue and
weakness of the striated muscle system. Non-striated
muscles including uterus are not affected. The prevalence
of MG is 14.1 patients per 100,000 (17.1 for women and 10.8
for men) without any ethnic, occupational, or endemic area
predilection, but although it affects both sexes, it has a
predilection for young females (with mean age of onset at
34.9 years) [1].
The most common symptoms at the onset of MG are ptosis
and diplopia, which occur in 65% of all patients, but only 10%
remain confined to the extrinsic ocular muscles [2]. In most
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doi:10.1016/j.ejcts.2005.11.022causing weakness of the proximal limb girdle and the bulbar
muscles with dysarthria, dysphagia, and poor mastication.
Generalized weakness and involvement of respiratory
muscles represent the final stage, which may lead to death
in more than 29% of untreated patients [2].
The course of MG is characterized by unpredictable
remissions and exacerbations. Exacerbations of MG are often
associated with physical or emotional stress. This may be
observed during pregnancy and the postpartum period.
The underlying autoimmune mechanism of MG is the
production of specific IgG antibodies directed against the
acetylcholine receptor (AchR) of the motor-endplate with
functional impairment. The initial cause of antibody forma-
tion is unknown, but the thymus, as the site of T-lymphocyte
education with resulting self-tolerance, is thought to be an
integral part in the pathogenesis of MG.
Thymectomy has been used to remove the main source of
antibody production since the first operation for MG by
Sauerbruch in 1911 [3]. Today, transsternal radical thymect-
omy is an effective part of the treatment of MG, as in long-
term evaluation more than half of the patients show
objective clinical improvement, with more than one quarter
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Table 1
Classification of the MG symptoms according to the Ossermann’s scale
Classification of Ossermann
I Ocular myasthenia characterized by ptosis and diplopia.
IIa Slow onset, frequently ocular, gradually spreading to the
skeletal musculature.
IIb Gradual onset with dysarthria, dysphagia, and poor mastication.
III Rapid onset of severe bulbar and skeletal muscle weakness
with involvement of the respiratory muscles.of complete remission. Two-third of patients lead a normal life
with normal everyday activity including regular sports [4].
The purpose of the present study was to evaluate the
effect of pregnancy and birth on the course of MG symptoms
and, most importantly, to compare the course of pregnancies
and deliveries before and after transsternal radical thy-
mectomy. In addition, the effect of thymectomy on the
development of the newborn was evaluated.IV Severe myasthenia gravis developing at least 2 years after onset.
Fig. 1. Evolution of the course of MG—Ossermann stage of the 15 pregnancies
before (interrupted line) or after (continuous line) thymectomy, in the period
before-, during- and after pregnancy.2. Patients and methods
Six women underwent transsternal radical thymectomy
for MG between 1986 and 1989 either before or after their
pregnancies.
The diagnosis of MG was confirmed by a neurologist’s
clinical assessment, electromyographic studies, edropho-
nium chloride (Tensilon) test, and circulating acetylcholine
receptor antibodies.
Indications for surgery included new onset of generalized
MG and failure of long-term conservative therapy. The
operative technique was median sternotomy, followed by
opening the pleural space and exploration of the mediasti-
num up to the cervical thymic extension and laterally down to
the phrenic nerves. All thymic tissues and the entire
pericardial fat and mediastinal fat from the diaphragm to
the thyroid were removed en bloc.
Six women of our patients had 15 pregnancies (n = 15),
eight before (group I) and seven after (group II) thymectomy.
All six women had all their pregnancies either before or after
the thymectomy.
The courses of MG-symptoms in the period before, during,
and after their pregnancies were evaluated by telephone
interviews and detailed written questionnaires until Novem-
ber 2002.
Data were collected in both groups on specific topics such
as changes of MG-symptoms with the menstruation cycle or
oral contraceptives, number and duration of pregnancies and
number of abortions or premature births, as well as intensity
and changes of MG-symptoms (both objectively, according to
the classification of Ossermann, and subjectively), myasthe-
nic crises, medications, or plasmaphereses needed in the
period before, during, and after pregnancy and birth.
Furthermore, the way, the duration and complication of
delivery, myasthenic symptoms of the newborn in the
postpartal period, breast-feeding, as well as inter-current
disease independent of MG during all these periods were
assessed.
Patients without symptoms or medication for MG were
considered to be in ‘‘complete remission.’’ ‘‘Improvement’’
was defined as lower stage and ‘‘deterioration’’ as higher
stage according to the classification of Ossermann (Table 1) in
comparison with the previous stage. Besides the Ossermann’s
classification, the subjective changes of symptoms, particu-
larly in intensity, which added no other symptoms to change
the Ossermann stage, have also been determined.
The study compared the stage of MG, before, during, and
after pregnancy, in order to compare the two groups, before
and after thymectomy. We also evaluated the complication
rate of the delivery and the newborn with MG symptoms
between groups.3. Results
At the time of the assessment, the mean age of the six
women was 42.6 years (range 32.7—55.6). Mean duration of
MG-symptoms was 23.2 years (range 15.4—35.8), mean time
after diagnosis of MG was 16.3 years (range 13.4—19.8) and
mean time after thymectomy was 14.6 years (range 13.3—
16.6). Mean time after delivery was 15.9 years (range
0.08—32).
Only one patient ever remarked some changes of MG-
symptoms along with the menstruation cycle, and among the
four patients who had ever taken some oral contraceptives,
no patient ever remarked any changes of MG-symptoms due
to this medication.
No mortality occurred. None experienced a myasthenic
crisis, nor required treatment with plasmapheresis.
All patients breast-fed their babies for up to 11 months
without problems.
The clinical course of all patients is summarized in Fig. 1.
Pregnancies before thymectomy (group I, n = 8): During
pregnancy, none of the patients improved, seven (87.5%)
showed no change, and one (12.5%) deteriorated by one
grade in terms of the Ossermann classification in comparison
to the value prior to the pregnancy.
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grade, and seven (87.5%) showed no change in comparison to
the period of pregnancy.
While pregnant, one patient (12.5%) showed subjective
improvement, five (62.5%) showed no change, and two (25%)
reported subjective deterioration of MG-symptoms.
In the postpartal period, subjectively, one (12.5%) showed
improvement, four (50%) showed no change, and three
(37.5%) a slight deterioration of MG-symptoms.
Three (37.5%) deliveries were spontaneous, two (25%)
were complicated by insufficient uterine contractions and
therefore needed external support such as vacuum extrac-
tion and manual abdominal pressure maneuvers, respec-
tively, and three (37.5%) were missed abortions (at 11, 12,
and 17 weeks gestation), which could not clearly be
attributed to MG. No caesarean section was needed. Mean
duration of birth was 5 h (range 20 min to 12 h).
In the postpartal period, two (40%) of the five newborns
(n = 5) in this group showed myasthenic symptoms such as
weak cry, problems in drinking or general weakness up to 6
weeks after labor.
In this group, no medical treatment of MG was necessary
during pregnancy.
Pregnancies after thymectomy (group II, n = 7): During
pregnancy, one patient (14.3%) improved by one grade of the
Ossermann classification, five (71.4%) showed no change, and
one (14.3%) a deterioration of one grade in comparison to the
stage.
In the postpartal period, one patient (14.3%) improved by
one grade and one (14.3%) by two grades of Ossermann
classification; three (42.9%) showed no change, and two
(28.6%) a clinical deterioration of one grade in comparison to
during pregnancy.
Subjectively, during pregnancy, two (28.6%) showed slight
improvement, four (57.1%) no change, and one (14.3%)
deterioration.
In the postpartal period, two patients (28.6%) showed
subjective improvement, three (42.9%) no change, and two
(28.6%) deterioration (the subjective changes correspond
exactly with the objective ones).
Five (71.4%) deliveries were spontaneous; one (14.3%) was
complicated by insufficient uterine contraction and there-
fore needed vacuum extraction, and one (14.3%) was a
caesarean section by absence of labor’s progression with
fetal suffering signs in cardiotocogram. No missed abortion
was reported. Mean duration of birth was 12.8 h (range
3.5—36).
None (0%) of the seven newborns suffered from myasthe-
nic symptoms.
Two patients (28.6%) needed medical treatment for MG
with prostigmine (one with 10—30 mg/day and one with 180—
240 mg/day) during pregnancy.4. Discussion
The influence of pregnancy on autoimmune disorders has
been of interest because of the tolerance of the immune
system in this particular period.
On the other hand, the effect of MG on pregnancy and
delivery, with or without thymectomy, is poorly studied.Thymectomy has been considered by many authors as the
treatment of choice for MG [4—8] and a positive effect has
been repeatedly demonstrated since the initial report by
Blalock et al. [9] in 1939. The beneficial effect of
thymectomy on MG is, therefore, generally accepted and
can also be confirmed with the present study. However, the
role of the thymus and the etiology of this disorder have yet
been fully elucidated.
For young women, the effect of the different treatment
modalities, especially of thymectomy, on the course of a
pregnancy is of great interest.
Obviously, analysis of the outcome of chronic and rare
diseases with unpredictable and fluctuating course is
difficult. In addition, a number of different classifications
for MG are used throughout the literature: Ossermann,
Ossermann modified, Oosterhuis, Myasthenia Gravis Founda-
tion of America, Besinger score, de Filippini, all of which try
to integrate the neurologist’s assessment and the patient’s
perception of disease-related symptoms and their limita-
tions. Therefore, it is difficult to assign the various
descriptions of symptoms of our patients to one objective
classification because none of them integrates the numerous
subjective variations of MG-manifestations described by the
patients. According to our previous studies [4,5], the
classification of Ossermann was used. In addition, we tried
to consider subjective changes which on one hand did not
make any difference according to the objective classifica-
tion, but on the other hand were significant regarding the
subjective perception of the disease.
There are a number of publications on the changes of MG-
symptoms during pregnancy. In the present study, however,
we focused on the effect of thymectomy on the course of MG-
symptoms during pregnancy, birth, and the postpartum
period. The main interest was to ascertain if thymectomy
could have a possible positive effect on the symptoms of MG
regarding pregnancy, and therefore, if thymectomy should
particularly be recommended to young women with MG who
are planning to have children.
We observed that each pregnancy, included these of the
same mother, had a singular pattern, which was not
necessarily similar to the course of the previous pregnancy.
Our present study confirms that the terms ‘‘variable’’ and
‘‘unpredictable’’ can be applied to the course of MG including
the period during pregnancy and also conversely on the effect
of pregnancy on MG. As 1899, Sinkler [10] reports that a
woman with MG improved during her sixth month of
gestation, but symptoms reappeared after delivery. Many
subsequent series have confirmed that approximately two
thirds of gravid myasthenic women either remain the same or
improve the symptoms of MG during their pregnancy, while
one third have an exacerbation of symptoms. Viets et al. [11]
in their review of the literature and presentation of 8
patients with 11 pregnancies, state unequivocally that the
course of MG in most cases is profoundly affected by
pregnancy. All their patients showed some change during
pregnancy with most patients experiencing remissions. In
four of their patients, there were no relapses in pregnancy.
The other four had both relapses and remissions with the
relapse occurring in the first trimester and subsequent
remission. Ossermann and Kaplan [12] reported 25 patients
with 36 pregnancies. In these patients, 33% had relapses with
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remission of their myasthenic symptoms during pregnancy.
Plauche [13] in his review of the English literature from 1938
to 1964 appraises 97 patients with 126 pregnancies. In this
report, 57% of all patients exhibited exacerbation at some
time during pregnancy, 46% had no change in symptoms, and
38% had remissions during the same period. He concluded
that there is no real difference between the number of
patients showing relapses or remissions in comparison with
the antepartum period. In his update from 1979 [14], he
noted that equal proportions of non-thymectomized patients
exhibit exacerbations, remissions, and no change in clinical
symptomatology. In the literature review of 322 pregnancies
from 1991 [15], he reported that 32% of the pregnancies
caused no change in the status of MG through gestation and
the postpartum period, 28.6% had at least partial remission,
and exacerbation occurred during gestation in 41% and in
29.8% in the puerperium. Reports of further investigators
confirmed the unpredictable nature of MG in pregnancy
[16,17], and so do our own results: most of the spontaneous
course of pregnancies (of non-thymectomized patients)
showed no change of MG-symptoms during gravidity and
the postpartum period (87.5%), but one (14.2%) exacerbated
during pregnancy and one (14.2%) improved in the post-
partum period.
Thus, the hypothesis of an increased tolerance of the
immune system during pregnancy with the spontaneous
expected positive effect of MG is not clearly demonstrated.
A majority of the previous publications described
worsening of MG symptoms immediately after delivery,
explained either by the reactivation of the body’s immuno-
logical response [18] or by puerperal infections such
endometritis, pyelonephritis, or cystitis [19], but in our
experience we cannot confirm these observations.
Reports on the effects of thymectomy on the course of
MG-symptoms regarding to gestation and postpartum
period are much less often found in literature. Ip et al.
[20] reported for the first time, a thymectomy for
treatment of a myasthenic crisis during pregnancy. There
are contradicting reports regarding the number and
severity of exacerbations in pregnancy in patients who
have had a thymectomy and in those who have not
undergone the procedure. In the case reported by Eden
and Gall [21] from 1983, a significant improvement of the
clinical course following thymectomy during subsequent
pregnancy could not be demonstrated. A review of previous
case reports [11,13,14,16,22,23], however, suggests that
although the incidence of remission in the thymectomy
group is lower than that of the non-thymectomy group, the
incidence of clinical exacerbation appears to be greater in
the non-thymectomy group. Clinical exacerbation occurred
in 60% of pregnancies in the non-thymectomy group as
compared to 30% in the thymectomy group [21]. Unfortu-
nately, our data could not confirm these trends: The course
of MG-symptoms of thymectomized as well as non-
thymectomized patients seems to be unpredictable during
both, pregnancy and postpartum period. Severe exacerba-
tions in pregnancies may occur after thymectomy as well as
there may be an enormous improvement in pregnancies
before thymectomy. Therefore, thymectomy seems to have
no remarkable effect on the course of the myasthenicsymptoms, however, there are benefits regarding a
pregnancy: Women who underwent thymectomy before
getting pregnant are in a better general condition and MG-
status. Consequently, if these women become pregnant,
they are able to support and manage a possible deteriora-
tion much better than a non-thymectomized women. Even
thymectomized women experience severe exacerbations,
they are still in a better state than non-thymectomized
women without exacerbation.
The question, if the newborn could profit of this positive
effect of the thymectomy of his mother, is not yet fully
clarified. In retrospective reviews of pregnant females with
and without thymectomy, there was no difference in the
development of neonatal MG between thymectomized and
non-thymectomized pregnant women [21,24]. Classically,
transitory neonatal myasthenia is a complication affecting
10—20% of children born by mothers who have MG [15], but
may reach up to 30% [19]. Symptoms usually occur several
hours or days following delivery and have a mean duration of
3 weeks, but may persist up to 3 months. The symptoms are
caused by transplacental transfer of acetylcholine receptor
antibodies, but there is no correlation between the severity
of maternal disease or the level of acethylcholine receptor
antibody titers and the occurrence of neonatal MG
[18,15,25].
In the present study, only 2 (16.7%) of the 12 newborns
alive showedmyasthenic symptoms. Both newborns belonged
to the group of non-thymectomized mothers. The rate of
neonatal MG was zero in children of thymectomized mothers,
in comparison to 40% in children of non-thymectomized
mothers, which denote another possible positive effect of
thymectomy.
The development of the newborn seems to be completely
independent of the presence or absence of the thymic gland
by the myasthenic mother [21]. Also, in our study, there are
neither alterations in length and weight of newborns of non-
thymectomized mothers, nor any remarkable effects on the
duration of labor until delivery of thymectomized mothers.
In our series, only one caesarean section (6.6%) was
performed, but a rate up to 17.4% is reported in the
literature [19]. Likewise, no difference between the two
groups was observed regarding premature birth, which was
reported to occur between 13% and 66% in non-thymecto-
mized patients [15,21,25]. We also did not observe
associated congenital anomalies which have been rarely
reported [25].5. Conclusions
The data show that transsternal radical thymectomy
improves MG-stage, which is correlated with a better course
of MG during pregnancy and the postpartum period, as in
most cases the absence of changes of MG-symptoms during
the gravidity and puerperium has been observed.
Importantly, no myasthenic symptoms in the newborn
after transsternal radical thymectomy of the mother have
been observed.
Because MG is classically affecting women at the child-
bearing age, we concluded that thymectomy could be
legitimately recommended in this subgroup of patients,
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specialists to monitor the evolution of the pregnancy and
delivery is needed.
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